Form 4 for BSX Boston Scientific
Accepted 2024-08-29 00:00:00 ET · period of report 2024-08-28 · accession 0001225208-24-008301 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-08-29 | 2024-08-28 | BSX | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | S - Sale | $80.00 | -14.1K | 176.4K | -7% | -$1.13M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-28 | S | D | 14,132 | $80.00 | 176,355 | D | — | — |